Introduction
This quiz collection is designed for M.Pharm students studying Regulatory Aspects of Food & Nutraceuticals. It focuses on foundational and regulatory concepts for nutraceuticals, dietary supplements and functional foods, linking definitions to real-world regulatory frameworks, quality standards, labeling, safety monitoring and evidence requirements. Questions probe distinctions between product categories, global regulatory pathways (US, EU, India), GMP and quality controls, claims substantiation and pharmacovigilance. The set challenges students to apply regulatory principles to formulation, manufacturing and post-market surveillance, preparing them for academic exams and practical regulatory decision-making in industry and regulatory affairs.
Q1. What is the most accurate regulatory distinction between a “nutraceutical” and a “pharmaceutical” in many jurisdictions?
- Nutraceuticals always contain herbal extracts while pharmaceuticals do not
- Nutraceuticals are regulated as foods or supplements with claims limited to nutrition or structure-function, while pharmaceuticals require pre-market approval for disease treatment
- Nutraceuticals require full clinical trials for efficacy before marketing, unlike pharmaceuticals
- Nutraceuticals can make disease treatment claims if supported by traditional use alone
Correct Answer: Nutraceuticals are regulated as foods or supplements with claims limited to nutrition or structure-function, while pharmaceuticals require pre-market approval for disease treatment
Q2. Under the US Dietary Supplement Health and Education Act (DSHEA), which statement best describes a permitted claim?
- A claim that the product cures a specific disease such as hypertension
- A structure-function claim describing how a nutrient affects normal body structure or function
- An efficacy claim requiring FDA pre-approval before marketing
- A guarantee of therapeutic equivalence to a prescription drug
Correct Answer: A structure-function claim describing how a nutrient affects normal body structure or function
Q3. Which regulatory body evaluates health claims for foods and supplements at the EU level?
- Food and Drug Administration (FDA)
- European Food Safety Authority (EFSA)
- World Health Organization (WHO)
- International Council for Harmonisation (ICH)
Correct Answer: European Food Safety Authority (EFSA)
Q4. “Novel Food” authorization in the European Union is required when:
- The food ingredient has a long history of safe consumption in the EU
- The ingredient has not been consumed to a significant degree within the EU prior to May 1997 (or is produced by new processes) and lacks a history of safe use
- The ingredient is a synthetic vitamin identical to a known nutrient
- The ingredient is a traditional herbal preparation already marketed in the EU
Correct Answer: The ingredient has not been consumed to a significant degree within the EU prior to May 1997 (or is produced by new processes) and lacks a history of safe use
Q5. Which US regulation specifically sets Good Manufacturing Practice (GMP) requirements for dietary supplements?
- 21 CFR Part 210
- 21 CFR Part 111
- 21 CFR Part 820
- 21 CFR Part 312
Correct Answer: 21 CFR Part 111
Q6. For a dietary supplement containing a botanical ingredient not marketed in the US before 1994, what regulatory action is typically necessary before marketing?
- No action — marketing is unrestricted
- Notification to FDA as a New Dietary Ingredient (NDI) with safety information
- Obtain a prescription-only classification
- Register as a pharmaceutical clinical trial
Correct Answer: Notification to FDA as a New Dietary Ingredient (NDI) with safety information
Q7. Which type of claim would most likely trigger classification of a product as an unapproved drug rather than a supplement?
- “Supports joint comfort and mobility”
- “Helps maintain healthy cholesterol levels as part of a balanced diet”
- “Treats and cures osteoarthritis by reducing inflammation in joints”
- “Contains antioxidants to support cellular health”
Correct Answer: “Treats and cures osteoarthritis by reducing inflammation in joints”
Q8. What is the principal purpose of stability testing for nutraceutical products?
- To determine the taste preferences of consumers
- To assess long-term safety in human populations
- To establish shelf-life, storage conditions, and to ensure label claims remain valid over time
- To prove therapeutic superiority over drugs
Correct Answer: To establish shelf-life, storage conditions, and to ensure label claims remain valid over time
Q9. Which post-market activity is essential for ongoing safety oversight of dietary supplements?
- Conducting randomized controlled trials for every product batch
- Implementing a robust adverse event and serious adverse event reporting system
- Issuing recalls only when requested by consumers
- Guaranteeing products are free of all contaminants regardless of testing
Correct Answer: Implementing a robust adverse event and serious adverse event reporting system
Q10. Which international reference is commonly used to define quality standards and identity tests for nutraceutical ingredients?
- United States Pharmacopeia (USP)
- Good Clinical Practice (GCP)
- ICH Q9 Risk Management
- Codex Alimentarius is irrelevant
Correct Answer: United States Pharmacopeia (USP)
Q11. Why are bioavailability and pharmacokinetic considerations particularly important for some nutraceuticals?
- They solely determine the taste of the product
- They affect systemic exposure, potential interactions with drugs, and the plausibility of health claims
- They are only important for injectable pharmaceuticals
- They are not relevant because nutraceuticals act locally in the gut
Correct Answer: They affect systemic exposure, potential interactions with drugs, and the plausibility of health claims
Q12. Which organization in India is primarily responsible for regulation of food, dietary supplements and nutraceuticals?
- Central Drugs Standard Control Organization (CDSCO)
- Food Safety and Standards Authority of India (FSSAI)
- Indian Council of Medical Research (ICMR)
- Pharmacy Council of India (PCI)
Correct Answer: Food Safety and Standards Authority of India (FSSAI)
Q13. What is a critical label requirement for many jurisdictions for dietary supplements or nutraceuticals?
- Listing of active ingredients, their amounts per serving, and any allergen declarations
- Guarantee of curing a specified disease
- Inclusion of clinical trial raw data
- List of manufacturing employees
Correct Answer: Listing of active ingredients, their amounts per serving, and any allergen declarations
Q14. Which analytical approach is most appropriate for verifying the identity and potency of botanical extracts in finished products?
- Organoleptic testing only
- Validated chromatographic methods (e.g., HPLC) with reference standards
- Rely solely on supplier certificates of analysis without testing
- Visual inspection of raw herb material
Correct Answer: Validated chromatographic methods (e.g., HPLC) with reference standards
Q15. What is the primary regulatory concern with contaminants such as heavy metals or pesticide residues in nutraceuticals?
- They improve the product’s efficacy
- They pose potential toxicological risks and may render the product non-compliant with safety standards
- They are ignored if the active ingredient label claim is accurate
- They can be listed as inactive ingredients
Correct Answer: They pose potential toxicological risks and may render the product non-compliant with safety standards
Q16. Which type of evidence is generally required to support a health claim for a functional food in a stringent regulatory environment?
- Anecdotal testimonials from users
- Robust human clinical trials demonstrating the claimed effect and causal relationship
- Traditional use without scientific data
- Manufacturer opinion pieces
Correct Answer: Robust human clinical trials demonstrating the claimed effect and causal relationship
Q17. What is a common regulatory expectation for Good Manufacturing Practices (GMP) in nutraceutical production beyond basic hygiene?
- Batch records, change control, validated cleaning and analytical methods, and product traceability
- Only wearing gloves is sufficient
- No documentation is required if the product is natural
- Marketing claims replace the need for manufacturing controls
Correct Answer: Batch records, change control, validated cleaning and analytical methods, and product traceability
Q18. Which post-marketing regulatory mechanism helps regulators detect safety signals for nutraceuticals?
- Pre-market advertising campaigns
- Adverse event surveillance, periodic safety reviews and signal detection from spontaneous reports
- Offering money-back guarantees
- Changing the product name frequently
Correct Answer: Adverse event surveillance, periodic safety reviews and signal detection from spontaneous reports
Q19. Why must formulators consider potential drug–nutrient interactions when developing nutraceutical products?
- Because such interactions can alter drug pharmacokinetics or pharmacodynamics, leading to reduced efficacy or increased toxicity
- Drug–nutrient interactions are only theoretical and never occur clinically
- Interactions always enhance drug efficacy
- Interactions are only relevant for parenteral drugs
Correct Answer: Because such interactions can alter drug pharmacokinetics or pharmacodynamics, leading to reduced efficacy or increased toxicity
Q20. Which practice can strengthen regulatory compliance and consumer trust for a nutraceutical manufacturer?
- Providing third-party verification (e.g., USP, NSF) and transparent quality documentation
- Reducing testing to minimize costs
- Using ambiguous labels and hidden ingredient lists
- Promising unverified cures on the label
Correct Answer: Providing third-party verification (e.g., USP, NSF) and transparent quality documentation
